Merck PCSK9 Pill Results Point to Extremely Low Cholesterol Future NYT Par :Gina Kolata 8 novembre 2025 à 20:01 The drug targets the PCSK9 protein, and could give millions of people a more affordable option to reduce their heart disease risk. © Andrew Kelly/ReutersMerck, which first introduced statins to the world nearly 40 years ago, announced that its new pill helped reduce heart attack and stroke rates in high risk patients by 20 percent in a year.
Connexion
